PX1 Research provides high-purity, US-manufactured Vilon (Lys-Glu) tailored for preclinical gastrointestinal research and intestinal stem cell assays. Every lot undergoes rigorous HPLC mass-spectrometry verification and endotoxin testing to ensure consistent, reproducible results in laboratory organoid models.
PX1 Research provides high-purity, US-manufactured Vilon (Lys-Glu) tailored for preclinical gastrointestinal research and intestinal stem cell assays. Every lot undergoes rigorous HPLC mass-spectrometry verification and endotoxin testing to ensure consistent, reproducible results in laboratory organoid models.
Principal investigators searching for a verified source to buy Vilon intestinal stem cells supplier materials require analytical transparency and high chemical purity. Vilon (L-Lysyl-L-glutamic acid) is a synthetic short peptide bioregulator studied extensively in preclinical models for its ability to alter chromatin accessibility and support intestinal stem cell proliferation.
To maintain assay reproducibility in organoid and enterocyte cultures, research teams should source Vilon peptide from qualified North American manufacturers. PX1 Research supplies laboratory-grade Vilon featuring comprehensive lot-specific documentation, including reverse-phase high-performance liquid chromatography (RP-HPLC) purity analysis, liquid chromatography-mass spectrometry (LC-MS) identity verification, and strict endotoxin limits.
Vilon is a short dipeptide composed of L-lysine and L-glutamic acid (H-Lys-Glu-OH). In peptide bioregulator literature, ultra-short peptide sequences are understood to interact directly with the major and minor grooves of genomic DNA. Preclinical nuclear binding assays indicate that Vilon binds preferentially to specific histone-DNA complexes, triggering localized chromatin unfolding.
By modulating histone acetylation and demethylation dynamics, Vilon increases transcriptional access to promoter regions associated with cellular renewal, protein synthesis, and enzymatic defense mechanisms. In murine and cell-culture models, this epigenetic activation enhances gene expression profiles without altering the primary nucleotide sequence, rendering it a primary focus in epigenetic gastroenterology research.
The gastrointestinal epithelium relies on continuous renewal driven by Lgr5+ intestinal stem cells (ISCs) located within the crypts of Lieberkühn. Preclinical studies suggest that short bioregulatory peptides like Vilon modulate signaling pathways critical to ISC self-renewal and differentiation along the enterocyte, goblet, and Paneth cell lineages.
In vitro models incorporating 3D intestinal organoids demonstrate that exposure to Vilon increases organoid budding efficiency, crypt-domain formation, and overall mucosal barrier resistance. Researchers utilize research peptides like Vilon to investigate mucosal repair kinetics under conditions of simulated oxidative stress, inflammatory cytokine exposure, or radiation-induced cellular senescence.
Evaluating Vilon within a broader research framework often involves comparing its activity against other well-characterized epithelial repair and bioregulatory peptides. While Vilon operates primarily through epigenetic chromatin remodeling and nuclear gene activation, compounds like BPC-157 target growth factor signaling pathways (such as VEGFR2 and FAK) to promote cell migration and angiogenesis in damaged tissues.
Similarly, research exploring systemic longevity and epigenetic regulation often pairs short di- and tetrapeptides like Vilon with Epithalon or gut-junction regulators such as Larazotide. Understanding these distinct mechanisms allows researchers to design multi-targeted in vitro protocols examining mucosal homeostasis across diverse cellular models within the broader context of Khavinson bioregulator research.
When integrating Vilon into intestinal stem cell assays, researchers typically introduce the compound into defined stem cell media alongside essential niche factors including Wnt3a, R-spondin-1, Noggin, and Epidermal Growth Factor (EGF). Preclinical concentration curves in published literature evaluate Vilon at working concentrations ranging from 10 nM to 10 µM depending on the assay duration and cellular density.
Observations in organoid cultures frequently track parameters such as surface area growth, crypt count, transepithelial electrical resistance (TEER), and alkaline phosphatase activity. Because short peptides can be susceptible to enzymatic cleavage by membrane-bound peptidases in unpurified primary tissue cultures, maintaining consistent media replacement schedules is critical for reliable longitudinal measurements.
Vilon is supplied by PX1 Research as a lyophilized white powder to maximize chemical stability during transport and storage. For laboratory preparation, the peptide should be reconstituted under a sterile laminar flow hood using sterile bacteriostatic water, sterile 0.9% sodium chloride, or laboratory-grade phosphate-buffered saline (PBS, pH 7.4).
Gentle swirling or brief vortexing is sufficient to achieve complete dissolution due to the high polarity and hydrophilic nature of the Lys-Glu sequence. Once reconstituted, stock solutions should be aliquoted into sterile microcentrifuge tubes to prevent degradation caused by repeated freeze-thaw cycles. Working stock concentrations are generally prepared at 1 mg/mL or 10 mM prior to dilution into culture media.
To preserve chemical integrity, unopened lyophilized Vilon vials must be stored at -20°C for short-to-medium term storage or -80°C for long-term repository maintenance. Desiccant containers should be used to protect the peptide from ambient atmospheric moisture during storage.
Reconstituted liquid solutions stored at 2°C to 8°C remain stable for immediate short-term experiment windows (typically up to 7–14 days), whereas aliquots frozen at -20°C or below remain stable for extended research periods. The primary degradation pathways for short dipeptides involve peptide bond hydrolysis under extreme pH levels or microbial contamination, underscoring the necessity of strict aseptic handling practices.
Choosing a qualified supplier for intestinal stem cell reagents requires evaluating verifiable analytical documentation. Low-grade or unverified peptide batches can introduce unquantified impurities, incorrect sequence synthesis, or excessive salt residues that compromise sensitive stem cell cultures.
PX1 Research enforces stringent quality control measures by testing every production lot through independent ISO 17025-accredited laboratories. Researchers can access lot-specific analytical reports detailing chemical purity verified by RP-HPLC and exact molecular mass confirmation via mass spectrometry directly through our research portal.
Intestinal stem cells and primary enterocyte cultures exhibit extreme sensitivity to lipopolysaccharides (LPS) and bacterial endotoxins. Elevated endotoxin levels in culture reagents induce unspecific inflammatory cascades, activating NF-κB pathways and altering baseline stem cell differentiation data.
PX1 Research manufactures Vilon in state-of-the-art cGMP-compliant facilities within the United States. Every lot undergoes quantitative Limulus Amebocyte Lysate (LAL) testing to guarantee endotoxin levels remain strictly below baseline threshold limits (<0.01 EU/mg), ensuring that experimental outcomes reflect true peptide activity rather than endotoxin-induced cellular artifacts.
Academic institutions, biotechnology firms, and contract research organizations (CROs) require dependable supply chains to support multi-phase experimental designs. PX1 Research offers streamlined procurement options for high-volume research applications through our dedicated wholesale laboratory portal.
Orders are dispatched directly from our dual logistical centers in California and Arizona. With same-day shipping on orders placed Monday through Friday prior to regional cutoff times, research institutions receive stable, temperature-controlled shipments to prevent project delays and ensure continuity in ongoing cell culture studies.
What is the primary application of Vilon in intestinal stem cell research?
Vilon (Lys-Glu) is utilized in preclinical research to study chromatin remodeling, gene expression modulation, and Lgr5+ intestinal stem cell renewal, organoid differentiation, and mucosal barrier repair in vitro.
What analytical documentation is provided with PX1 Research Vilon?
Every lot of Vilon includes a lot-specific Certificate of Analysis (COA) detailing RP-HPLC purity (>98%), mass spectrometry (LC-MS) identity validation, and quantitative LAL endotoxin testing.
Why is low endotoxin content critical for intestinal organoid assays?
Endotoxins (LPS) trigger inflammatory responses via TLR4 signaling in stem cells, leading to premature cell death or skewed differentiation profiles. PX1 Research maintains strict endotoxin controls to prevent culture contamination.
How should lyophilized Vilon be stored upon arrival?
Lyophilized Vilon should be kept desiccated and stored at -20°C for standard storage or -80°C for long-term preservation to maintain chemical stability.
What solvents are recommended for reconstituting Vilon in laboratory settings?
Vilon reconstitutes readily in sterile bacteriostatic water, sterile 0.9% saline, or sterile phosphate-buffered saline (PBS, pH 7.4). Avoid strong acid or alkaline buffers that could promote hydrolysis.
How does Vilon compare structurally to other Khavinson bioregulators?
Vilon is a short dipeptide (Lys-Glu), whereas other Khavinson bioregulators such as Epithalon (Ala-Glu-Asp-Gly) are tetrapeptides. All bioregulators in this class function via nuclear binding and epigenetic gene regulation.
Can Vilon stock solutions undergo multiple freeze-thaw cycles?
Repeated freeze-thaw cycles degrade peptide bonds over time. Researchers should divide freshly reconstituted Vilon into single-use micro-aliquots prior to freezing at -20°C.
Where is PX1 Research Vilon synthesized and shipped from?
PX1 Research Vilon is manufactured in GMP-compliant facilities within the USA and shipped directly from distribution hubs located in California and Arizona.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.